Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Farah Choudhry

Pediatrics Middlebury, CT Medical Doctor

NPI 1821061664 CMS profile 36722

1625 Straits Tpke, Middlebury, CT 06762

Open in the dashboard

General payments

$4,400

201 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Farah Choudhry of Middlebury, CT is reported in the CMS Open Payments database as having received $4,400 across 201 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $965 40
2024 General $701 28
2023 General $884 33
2022 General $399 22
2021 General $482 27
2020 General $633 31
2019 General $335 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Farah Choudhry
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Farah Choudhry were reported at $965. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Farah Choudhry Pediatrics median Middle half National median
2019 $335 $86 $31–$183 $163
2020 $633 $49 $22–$110 $114
2021 $482 $68 $27–$158 $132
2022 $399 $77 $30–$173 $149
2023 $884 $88 $33–$190 $160
2024 $701 $94 $34–$206 $164
2025 $965 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $715 33 payments
  2. Ironshore Pharmaceuticals Inc. $394 19 payments
  3. Sanofi Pasteur Inc. $381 15 payments
  4. Cranial Technologies, Inc $349 22 payments
  5. Merck Sharp & Dohme Corporation $280 16 payments
  6. Regeneron Healthcare Solutions, Inc. $243 2 payments
  7. kaleo, Inc. $192 11 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $179 9 payments
  9. Genzyme Corporation $125 1 payment
  10. Alexion Pharmaceuticals, Inc. $124 5 payments
  11. Other $1,418 68 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,400 201 payments
Products named General payments · program years 2019–2025
  1. EUCRISA $401 18 payments
  2. Doc Band $349 22 payments
  3. GARDASIL 9 $267 15 payments
  4. DUPIXENT $243 2 payments
  5. JORNAY PM $234 10 payments
  6. ROTATEQ $222 13 payments
  7. BEYFORTUS $216 8 payments
  8. TRUMENBA $210 10 payments
  9. COMIRNATY $200 10 payments
  10. VAXNEUVANCE $190 10 payments
  11. Other $3,740 179 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

201 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record